title: Rational development of peptide vaccination in clinical oncology.
authors.forename: U
authors.initials: U
authors.lastname: Keiholz
authors.forename: C
authors.initials: C
authors.lastname: Scheibenbogen
authors.forename: E
authors.initials: E
authors.lastname: Theil
authors.forename: D
authors.initials: D
authors.lastname: Schadendorf
mesh_terms: D000951:Antigens, Neoplasm; D002986:Clinical Trials as Topic; D006801:Humans; D016233:Immunotherapy, Active; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D009363:Neoplasm Proteins / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*; D016896:Treatment Outcome; D022223:Vaccines, Subunit / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D000951:Antigens, Neoplasm; C072013:MAGEA3 protein, human; D009363:Neoplasm Proteins; D022223:Vaccines, Subunit